Online inquiry

IVTScrip™ mRNA-Human AADAT, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8712MR)

This product GTTS-WK8712MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AADAT protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001286682.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51166
UniProt ID Q8N5Z0
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AADAT, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8712MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK8170MR IVTScrip™ mRNA-Human ABHD5, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ABHD5
GTTS-WK0901MR IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA Intestinal Alkaline Phosphatase
GTTS-WK28442MR IVTScrip™ mRNA-Human ATAT1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ATAT1
GTTS-WK15680MR IVTScrip™ mRNA-Human AKR7A3, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AKR7A3
GTTS-WK26039MR IVTScrip™ mRNA-Human ATAD3B, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ATAD3B
GTTS-WK18701MR IVTScrip™ mRNA-Human ALDH3B1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ALDH3B1
GTTS-WK19368MR IVTScrip™ mRNA-Human ANAPC11, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANAPC11
GTTS-WK17877MR IVTScrip™ mRNA-Human ANGEL1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANGEL1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW